NovaBridge Biosciences
General ticker "NBP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $273.7M (TTM average)
NovaBridge Biosciences does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 4.4%: low 1.46$, high 1.59$
Factors to consider:
- Earnings expected soon, date: 2026-06-29 bmo
- Total employees count: 185 as of 2019
- Current price 31.1% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.28$, 6.63$]
- 2026-12-31 to 2027-12-31 estimated range: [1.56$, 4.77$]
Financial Metrics affecting the NBP estimates:
- Positive: with PPE of -12.7 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 59.87 > -0.60
- Positive: Shareholder equity ratio, % of 88.65 > 64.29
Short-term NBP quotes
Long-term NBP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY4.49MM | CNY0.00MM | CNY0.00MM |
| Operating Expenses | CNY515.65MM | CNY375.36MM | CNY13.48MM |
| Operating Income | CNY-511.16MM | CNY-375.36MM | CNY-13.48MM |
| Non-Operating Income | CNY-954.53MM | CNY12.63MM | CNY0.85MM |
| Interest Expense | CNY0.10MM | CNY0.00MM | CNY0.00MM |
| R&D Expense | CNY114.36MM | CNY158.90MM | CNY8.99MM |
| Income(Loss) | CNY-1,465.69MM | CNY-362.73MM | CNY-12.63MM |
| Taxes | CNY-1,258.93MM | CNY0.00MM | CNY0.00MM |
| Net Income(Loss)* | CNY-1,465.69MM | CNY-362.72MM | CNY-6.61MM |
| Stockholders Equity | CNY242.58MM | CNY1,468.23MM | CNY33.02MM |
| Assets | CNY368.92MM | CNY1,552.31MM | CNY37.24MM |
| Operating Cash Flow | CNY-72.85MM | CNY-384.29MM | CNY-20.60MM |
| Capital expenditure | CNY0.16MM | CNY0.35MM | CNY0.01MM |
| Investing Cash Flow | CNY-107.63MM | CNY-992.42MM | CNY104.97MM |
| Financing Cash Flow | CNY-8.25MM | CNY-2.44MM | CNY57.73MM |
| Earnings Per Share** | CNY-17.62 | CNY-4.47 | CNY-0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.